Cargando…
Optimizing Chemotherapy: Concomitant Medication Lists
Identifying sources of variability in the response to cancer chemotherapy requires knowledge of all variables including concomitant medications, which can alter metabolism and pharmacokinetics of chemotherapy. This study investigated the accuracy of concomitant medication lists in the charts of canc...
Autores principales: | Hanigan, Marie H., dela Cruz, Brian L., Shord, Stacy S., Medina, Patrick J., Fazili, Javid, Thompson, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826435/ https://www.ncbi.nlm.nih.gov/pubmed/21124312 http://dx.doi.org/10.1038/clpt.2010.253 |
Ejemplares similares
-
US Food and Drug Administration embraces using innovation to identify optimized dosages for patients with cancer
por: Shord, Stacy S., et al.
Publicado: (2023) -
Paclitaxel alters the expression and specific activity of deoxycytidine kinase and cytidine deaminase in non-small cell lung cancer cell lines
por: Shord, Stacy S, et al.
Publicado: (2009) -
Study design considerations to assess the impact of potential drug–drug interactions in first‐in‐human studies in oncology drug development
por: Subramaniam, Sriram, et al.
Publicado: (2023) -
Concomitant continuous infusion chemotherapy and radiation /
Publicado: (1991) -
Efficiently sparse listing of classes of optimal cophylogeny reconciliations
por: Wang, Yishu, et al.
Publicado: (2022)